Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Posted March 20, 2020.
Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
